KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $141.98 $159.34 Friday, 26th Apr 2024 ALNY stock ended at $143.31. This is 0.278% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.14% from a day low at $143.00 to a day high of $146.07.
90 days $141.98 $181.66
52 weeks $141.98 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Feb 14, 2024 $162.57 $164.63 $161.51 $164.15 842 370
Feb 13, 2024 $164.89 $166.50 $160.84 $162.00 792 456
Feb 12, 2024 $170.01 $171.55 $166.87 $169.34 782 410
Feb 09, 2024 $169.49 $171.86 $168.54 $170.03 480 589
Feb 08, 2024 $168.57 $170.25 $165.59 $169.50 882 012
Feb 07, 2024 $172.55 $172.55 $167.43 $168.60 582 107
Feb 06, 2024 $170.65 $173.18 $169.81 $172.18 1 430 391
Feb 05, 2024 $172.17 $172.73 $168.00 $170.70 571 163
Feb 02, 2024 $172.76 $174.48 $169.32 $173.06 628 061
Feb 01, 2024 $173.54 $176.35 $172.21 $174.92 562 129
Jan 31, 2024 $179.49 $179.80 $172.37 $172.91 810 946
Jan 30, 2024 $180.45 $181.66 $178.36 $180.12 467 107
Jan 29, 2024 $179.13 $181.50 $176.12 $180.96 1 021 352
Jan 26, 2024 $183.88 $184.29 $179.47 $179.62 431 694
Jan 25, 2024 $185.43 $188.69 $183.03 $183.93 518 615
Jan 24, 2024 $190.72 $191.72 $185.13 $185.20 516 165
Jan 23, 2024 $184.76 $190.31 $183.45 $189.70 628 880
Jan 22, 2024 $183.88 $189.98 $182.60 $183.92 572 717
Jan 19, 2024 $186.14 $186.27 $182.53 $184.03 404 627
Jan 18, 2024 $189.00 $189.00 $183.67 $185.95 469 256
Jan 17, 2024 $186.43 $188.83 $182.73 $188.56 468 631
Jan 16, 2024 $192.05 $192.05 $186.22 $187.49 586 963
Jan 12, 2024 $195.11 $196.49 $192.77 $193.39 381 421
Jan 11, 2024 $194.76 $196.80 $192.43 $195.08 615 749
Jan 10, 2024 $198.51 $199.24 $190.37 $196.61 536 680
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT